Join the Carboplatin group to help and get support from people like you.
Carboplatin News
Platinum Chemo Shortage Led to Reduced Use, No Change in Mortality
MONDAY, Dec. 30, 2024 – The platinum chemotherapy shortage, first announced on Feb. 10, 2023, resulted in a modest absolute reduction in platinum use, but no difference in mortality, according to a...
Last Year's Platinum-Based Drugs Shortage Didn't Raise Cancer Deaths, Study Found
TUESDAY, Dec. 24, 2024 – When supplies of certain generic, platinum-based cancer chemotherapies dwindled in 2023, oncologists feared it might lead to under-treatment and many more cancer deaths....
New Drug Regimen Extends Survival for Cervical Cancer Patients
THURSDAY, Oct. 17, 2024 – In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death...
FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter
including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot...
FDA Medwatch Alert: Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified
ISSUE: Hospira, Inc. is further informing the general public about a previously communicated voluntary user-level recall of three lots of Carboplatin Injection due to visible particulates identified...
FDA Medwatch Alert: Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials
Including certain lots of the following products: carboplatin cytarabine paclitaxel methotrexate [Posted 07/16/2012] ISSUE: Hospira and FDA notified healthcare professional of a nationwide recall...